Journal of the American Society of Hypertension
Volume 3, Issue 2 , Pages 150-155 , March 2009

Treatment of hypertension in patients with diabetes—an update

  • George L. Bakris, MD

      Affiliations

    • Hypertensive Diseases and Diabetes Center, Department of Medicine, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA
    • Corresponding Author InformationCorresponding author: George L. Bakris, MD, Hypertensive Diseases Center, University of Chicago Pritzker School of Medicine, 5841 South Maryland Avenue, MC 1027, Chicago, Illinois 60637. Tel: 773-702-7936; fax: 773-834-0486.
    • ,
  • James R. Sowers, MD

      Affiliations

    • The Diabetes and Cardiovascular Center, Department of Medicine and Physiology, University of Missouri-Columbia School of Medicine and VA Center, Columbia, Missouri, USA
    • ,
  • on behalf of the American Society of Hypertension Writing Group

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Reprinted with Permission from the Journal of Clinical Hypertension, Vol. 10, No. 9 September 2008, pgs. 707–713.

 Dr Bakris is a consultant for Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi-Sankyo, Forest Laboratories, Gilead, GlaxoSmithKline, Merck, Novartis, Sanofi Aventis, and Walgreens (formulary committee). He has received Grant/Research support from the National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases/National Heart, Lung, and Blood Institute), GlaxoSmithKline, and Forest Laboratories. Dr Sowers has received Grant/Research support from the National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases/National Heart, Lung, and Blood Institute), VA, and Forest Laboratories. Dr Sowers is a consultant for Forest Laboratories, Merck, and Novartis.

PII: S1933-1711(09)00003-5

doi: 10.1016/j.jash.2009.01.001

Journal of the American Society of Hypertension
Volume 3, Issue 2 , Pages 150-155 , March 2009

Article Tools

* Image Usage & Resolution